Who can prescribe Strattera? NP vs MD in New York

If you’re navigating ADHD treatment options, you’ve likely wondered whether you can access non-stimulant medications like Strattera through telehealth. The short answer is yes—in most cases, you absolutely can. But understanding the nuances of federal and state regulations, medication options, and what to expect from a legitimate telehealth provider will help you make informed decisions about your care.

This comprehensive guide walks you through everything you need to know about getting ADHD non-stimulant medications prescribed online, including current regulations, state-specific rules, and how to access safe, effective treatment from home.

Understanding ADHD Non-Stimulant Medications

What Are Non-Stimulant ADHD Medications?

Non-stimulant medications offer an alternative treatment path for ADHD, particularly for individuals who can’t tolerate stimulants or have concerns about controlled substances. The most commonly prescribed non-stimulant is atomoxetine (Strattera), which works differently than stimulants like Adderall or Ritalin.

Strattera is not a controlled substance, which fundamentally changes how it can be prescribed via telehealth. Unlike Schedule II stimulants, it doesn’t carry federal restrictions on remote prescribing, making it more accessible through online platforms.

How Strattera Differs from Stimulant Medications

Key differences include:

• No abuse potential: Strattera isn’t habit-forming and doesn’t produce the euphoric effects associated with stimulants
• Gradual onset: Effects typically develop over 4–6 weeks, unlike stimulants which work within hours
• All-day coverage: Provides consistent symptom management without wearing off
• Flexible prescribing: Can be prescribed in 90-day supplies with refills, unlike stimulants requiring monthly prescriptions
• No DEA restrictions: Providers can prescribe it through telehealth without special federal requirements

That said, Strattera does carry FDA warnings for suicidal ideation in youth and potential liver toxicity, so proper monitoring is essential—something quality telehealth providers take seriously.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

The Current State of Telehealth ADHD Treatment

Federal Regulations: What You Need to Know

As of December 2025, the landscape for telehealth ADHD prescribing remains in transition. The DEA’s pandemic-era telehealth flexibilities have been extended through December 31, 2025, allowing providers to prescribe Schedule II–V controlled substances (including stimulants) via telehealth without a prior in-person examination.

However, this temporary rule doesn’t affect non-stimulant medications like Strattera. Since Strattera isn’t a controlled substance, it was never subject to the Ryan Haight Act’s in-person exam requirement in the first place. This means providers have always been able to prescribe it via telehealth under standard telemedicine practices.

What Happens After December 31, 2025?

The DEA is expected to announce a fourth extension or finalize new permanent rules for 2026. If no extension occurs, the original Ryan Haight Act requirements could resume for controlled substances, potentially requiring in-person exams for stimulant medications.

For patients seeking non-stimulant treatment, this regulatory uncertainty doesn’t apply. Strattera and other non-controlled ADHD medications can continue to be prescribed via telehealth regardless of DEA rule changes.

State-by-State Telehealth Rules for ADHD Treatment

While federal law sets the baseline, individual states add their own requirements. Here’s what you need to know about key states:

California: Telehealth-Friendly with Minimal Restrictions

California allows comprehensive telehealth ADHD treatment without mandating in-person visits for non-controlled medications. A video evaluation satisfies the ‘good faith exam’ standard, enabling providers to prescribe Strattera after a thorough online assessment.

Nurse practitioners in California have independent practice authority after meeting experience requirements, meaning they can evaluate and prescribe ADHD medications without physician oversight.

New York: Stricter for Controlled Substances, Not Non-Stimulants

New York implemented a final rule in May 2025 requiring an initial in-person evaluation before prescribing any controlled substance via telemedicine. This affects stimulant ADHD medications but does not apply to Strattera, which can be prescribed through telehealth without an in-person visit.

New York NPs have independent practice authority after completing 3,600 supervised hours, allowing them to diagnose ADHD and prescribe non-controlled medications.

Florida: Mental Health Exception Supports ADHD Care

Florida generally prohibits telehealth prescribing of Schedule II stimulants unless treating a psychiatric disorder—which includes ADHD. For non-controlled medications like Strattera, Florida imposes no special restrictions on telehealth prescribing.

Providers must check Florida’s Prescription Drug Monitoring Program (PDMP) before every controlled substance prescription, though this doesn’t apply to Strattera.

Texas: Telehealth-Friendly for Mental Health

Texas embraces telehealth for behavioral health services, including ADHD treatment. No state-mandated in-person visit is required for non-controlled ADHD medications.

However, Texas has unique restrictions on nurse practitioner prescribing: NPs and PAs can only prescribe Schedule II stimulants in hospital or hospice settings. Outside these contexts, they’re limited to Schedule III–V medications. This doesn’t affect physicians, who can prescribe stimulants via telehealth, nor does it restrict anyone from prescribing Strattera.

Alabama: Among the Strictest Requirements

Alabama requires an in-person visit within 12 months for ongoing telehealth treatment, with an important exception: mental health services are exempt from this rule. Since ADHD falls under psychiatric care, this exemption may apply.

Alabama also requires that certain licensed medical personnel be physically present with the patient during telehealth visits for initial controlled substance prescriptions. Again, this doesn’t impact Strattera prescribing.

New Hampshire: Recently Modernized Approach

New Hampshire removed its prior in-person requirement in August 2025 (SB 252), now only requiring an annual follow-up evaluation—which can be conducted via telehealth—for controlled substance prescribing. This makes NH more accessible for telehealth ADHD treatment than ever before.

For non-controlled medications, NH has no special restrictions beyond standard telemedicine practices.

How Telehealth ADHD Prescribing Actually Works

What to Expect from Your First Appointment

Legitimate telehealth ADHD evaluations mirror in-person assessments in depth and rigor. Here’s the typical process:

1. Comprehensive IntakeYou’ll complete detailed questionnaires about your symptoms, medical history, previous treatments, and how ADHD affects your daily life. Reputable providers use standardized rating scales aligned with DSM-5 diagnostic criteria.

2. Video ConsultationA licensed clinician—typically a psychiatrist, psychiatric nurse practitioner, or physician—will conduct a thorough video interview. They’ll ask about:

• Symptom patterns across different settings (work, home, relationships)
• Onset and duration of symptoms
• Previous diagnoses or treatments
• Family history of ADHD or mental health conditions
• Current medications and health conditions
• Substance use history

3. Diagnostic AssessmentThe provider will determine whether you meet diagnostic criteria for ADHD. They may request collateral information from family members or review old report cards to confirm childhood symptom onset.

4. Treatment PlanningIf diagnosed, your provider will discuss treatment options, including both medication and non-medication approaches. They’ll explain the differences between stimulants and non-stimulants, helping you make an informed choice.

5. Prescription and Follow-UpIf appropriate, they’ll e-prescribe medication to your pharmacy. For Strattera, you can typically receive a 90-day supply. The provider will schedule follow-up appointments to monitor your response and adjust treatment as needed.

Documentation You May Need

Quality telehealth providers require proper documentation:

• Government-issued photo ID (to verify identity and age)
• Current address verification (for state licensing compliance)
• Insurance information (if using insurance)
• Previous medical records (if available)
• List of current medications
• Pharmacy information

Red Flags That Disqualify Telehealth Treatment

Reputable providers screen carefully for safety. You may not be eligible for telehealth ADHD medication if you have:

• Uncontrolled cardiovascular conditions
• Severe, untreated psychiatric conditions
• Active substance use disorder
• History of medication misuse
• Conditions requiring in-person monitoring

This isn’t about denying care—it’s about ensuring safety. Providers may recommend in-person evaluation with a specialist or suggest starting with therapy before medication.

Can Nurse Practitioners Prescribe ADHD Medications?

This depends entirely on your state. For non-stimulant medications like Strattera, nurse practitioners in all states can prescribe with at least a collaborative physician agreement. Many states now grant NPs full independent authority.

States with Independent NP Prescribing

• California: Independent practice after experience requirements
• New York: Independent after 3,600 supervised hours
• Illinois: Full practice authority after 4,000 hours
• New Hampshire: Complete independent practice
• Over 20 other states: Various independent practice models

States Requiring Collaboration

• Florida: Physician collaboration required; NPs can prescribe Schedule II with collaboration but limited to 7-day supply
• Texas: Collaboration required; Schedule II only in hospital/hospice settings
• Pennsylvania: Collaborative agreement required; 30-day limit on initial Schedule II prescriptions
• Georgia: Collaboration required; NPs cannot prescribe Schedule II at all

For Strattera specifically, these restrictions don’t apply as strictly since it’s not a controlled substance. NPs with collaborative agreements can prescribe it in all states.

Comparing Telehealth ADHD Medication Options

The Recent Scrutiny on Telehealth ADHD Prescribing

The telehealth ADHD space faced significant scrutiny in 2022–2023 when major platforms like Cerebral and Done came under DEA and DOJ investigation for allegedly over-prescribing stimulants without adequate oversight. Cerebral ultimately stopped prescribing most controlled substances.

What this means for patients in 2025:

Legitimate telehealth providers have significantly tightened their protocols:

• More comprehensive diagnostic evaluations
• Regular follow-up appointments (often monthly initially)
• Coordination with primary care providers
• Some require periodic drug screens for stimulant prescriptions
• Clear documentation of symptom improvement and ongoing need

This is actually positive for patients. Stricter practices protect both patient safety and continued telehealth access by preventing regulatory crackdowns.

How Klarity Health Approaches ADHD Treatment

At Klarity Health, we understand that accessing ADHD treatment shouldn’t be complicated by confusing regulations or concerns about legitimacy. Our approach prioritizes both accessibility and clinical excellence:

Comprehensive Evaluations

Every patient receives a thorough diagnostic assessment from licensed psychiatrists or psychiatric nurse practitioners. We use evidence-based DSM-5 criteria and never ‘guarantee’ prescriptions—your treatment plan depends on your individual needs and safety profile.

Licensed Providers in Your State

We ensure every provider is fully licensed in your state and understands local regulations. Whether you’re in California, Texas, New York, or anywhere else, you’ll see a clinician authorized to practice where you live.

Transparent Pricing and Insurance Options

We accept both insurance and offer transparent cash-pay pricing, so you know exactly what to expect. No surprise bills or hidden fees—just straightforward access to quality mental healthcare.

Ongoing Support

ADHD treatment doesn’t end with a prescription. We provide regular follow-ups to monitor your response, adjust dosing as needed, and ensure your treatment plan continues working for you. Our providers can coordinate with your other healthcare professionals to provide truly integrated care.

Flexible Medication Options

Our providers discuss both stimulant and non-stimulant options, helping you understand the benefits and considerations of each. If Strattera or another non-stimulant is appropriate for your situation, we can prescribe it and ship it directly to your preferred pharmacy.

Frequently Asked Questions

Q: Do I need an in-person visit before getting prescribed ADHD medication online?

For non-stimulant medications like Strattera, no federal law requires an in-person visit. Most states also don’t require this for non-controlled substances. A comprehensive telehealth video evaluation is sufficient. For stimulant medications, requirements vary by state—some like New York now require an initial in-person evaluation for any controlled substance, while most others allow telehealth-only treatment under current federal rules.

Q: Can I get a 90-day supply of ADHD medication through telehealth?

Yes, for non-stimulant medications like Strattera. Since it’s not a controlled substance, providers can prescribe longer supplies with refills. Stimulant medications are limited to 30-day supplies without refills due to Schedule II regulations, requiring a new prescription each month.

Q: Will my pharmacy fill a prescription from an online doctor?

Yes, in the vast majority of cases. Electronic prescriptions are standard practice and pharmacies don’t distinguish between telehealth and in-person visits. Using a reputable telehealth service and maintaining a relationship with one pharmacy helps ensure smooth prescription fills. Strattera prescriptions face virtually no scrutiny since they’re not controlled substances.

Q: What if I move to a different state while in treatment?

You’ll need to transition to a provider licensed in your new state. Telehealth licenses are state-specific, so your current provider can’t continue treating you across state lines. Reputable platforms like Klarity can help facilitate this transition to ensure continuity of care.

Q: Is Strattera as effective as stimulant medications?

Strattera works differently than stimulants and is highly effective for many patients, though individual responses vary. Studies show about 70% of people respond well to Strattera, compared to 70-80% for stimulants. It takes longer to work (4-6 weeks for full effect versus hours for stimulants) but provides all-day coverage without the potential for abuse. Many patients prefer it precisely because it’s not a controlled substance and offers consistent, non-jittery symptom management.

Q: What side effects should I watch for with Strattera?

Common side effects include decreased appetite, nausea, upset stomach, dizziness, fatigue, and mood changes. Strattera can increase blood pressure and heart rate, so your provider will monitor these. Rare but serious side effects include liver problems and increased suicidal thoughts, particularly in children and adolescents—which is why regular follow-ups are essential.

Q: How much does telehealth ADHD treatment cost?

Costs vary significantly. Many platforms charge $99-$299 for initial consultations and $59-$149 for follow-ups. With insurance, copays typically apply as they would for in-person mental health visits. At Klarity Health, we accept most major insurance plans and offer transparent cash pricing, making quality ADHD care accessible regardless of your insurance situation.

Q: Can I use telehealth for my child’s ADHD?

Most telehealth platforms focus on adults (18+) for controlled substance prescribing due to regulatory complexity. Some platforms treat teenagers with parental consent. For children under 12, most providers recommend in-person pediatric ADHD evaluation. Non-stimulant medications may have more flexibility, but always check the specific platform’s age policies.

Looking Ahead: What to Expect in 2026 and Beyond

The telehealth ADHD treatment landscape continues evolving. Here’s what may change:

Potential Regulatory Developments

• DEA permanent rules: The agency is working on a permanent telemedicine framework, possibly including a special registration system for telehealth prescribers
• State legislation: More states are likely to clarify and modernize their telehealth laws
• Congressional action: Bills like the TREATS Act could expand cross-state telehealth access

What This Means for Non-Stimulant Treatment

Regardless of how controlled substance regulations evolve, non-stimulant ADHD medications like Strattera will remain accessible via telehealth. They’re not subject to the same restrictions and have always been prescribable through telemedicine under standard medical practice guidelines.

Staying Informed

If you’re using telehealth for ADHD treatment:

• Stay in regular contact with your provider
• Attend all scheduled follow-ups
• Watch for communications about regulatory changes
• Have a backup plan if rules change (your provider can help coordinate)

Making Telehealth ADHD Treatment Work for You

Choosing a Reputable Provider

Look for services that:

• Use licensed clinicians (MD, DO, or NP)
• Require comprehensive video evaluations
• Follow DSM-5 diagnostic criteria
• Discuss both medication and non-medication options
• Schedule regular follow-ups
• Have transparent pricing and clear policies
• Don’t ‘guarantee’ prescriptions

Warning signs to avoid:

• Rubber-stamp prescriptions after minimal evaluation
• No discussion of risks or alternatives
• Phone-only evaluations (video is standard)
• Guaranteed medication regardless of evaluation
• Pressure to choose specific treatments

Being an Active Participant

Quality telehealth care requires your engagement:

• Be thorough and honest: Share complete information about symptoms, history, and any substance use
• Attend follow-ups: Regular monitoring ensures your treatment works safely
• Communicate changes: Report side effects or changes in symptoms promptly
• Take medications as prescribed: Even non-controlled medications require proper use
• Stay organized: Manage refill requests, appointments, and pharmacy coordination

Integrating Comprehensive Care

Medication is just one component of ADHD management. Consider:

• Cognitive-behavioral therapy (CBT) for ADHD
• Coaching for practical skills and accountability
• Lifestyle modifications (sleep, exercise, nutrition)
• Organizational strategies and tools
• Support groups or peer support

Many telehealth platforms, including Klarity Health, can coordinate therapy alongside medication management for truly comprehensive treatment.

Take the Next Step Toward Better ADHD Management

If you’ve been struggling with ADHD symptoms and wondering whether telehealth treatment could work for you, the answer is likely yes. Non-stimulant medications like Strattera offer an accessible, effective option without the regulatory complexity of controlled substances.

Ready to explore your options? Klarity Health makes it simple to connect with licensed providers who understand both ADHD treatment and the unique considerations of telehealth care. Our comprehensive evaluations ensure you receive personalized treatment that fits your needs, lifestyle, and medical history.

With provider availability across the United States, acceptance of most insurance plans, and transparent cash-pay pricing, accessing quality ADHD care has never been more straightforward. Schedule your evaluation today and take the first step toward clearer thinking, better focus, and improved daily functioning.

References

1. FierceHealthcare. (2024, November). ‘DEA Finalizes One-Year Extension for Controlled Substance Prescribing via Telehealth.’ Retrieved from www.fiercehealthcare.com

2. McDermott Will & Emery. (2025). ‘DEA Signals Extension of Telemedicine Flexibilities for Controlled Substance Prescribing for 2026.’ Retrieved from www.mwe.com

3. Sheppard Mullin Healthcare Law Blog / National Law Review. (2025, August). ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Retrieved from www.sheppardhealthlaw.com

4. RxAgent. (2025, October). ‘The Telehealth Compliance Trap: What Prescribers Need to Know.’ Retrieved from www.rxagent.co

5. Medical News Today. (2025, January). ‘Is Strattera a Controlled Substance?’ Retrieved from www.medicalnewstoday.com

This article was verified as accurate as of December 17, 2025. ADHD treatment regulations continue to evolve. Always consult with a licensed healthcare provider for personalized medical advice and verify current regulations in your state.

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment